Clinical risk prevention indicators in preimplantation genetic testing
With the rapid development of preimplantation genetic testing(PGT)technology in recent years,risks in clinical application have arisen at the same time.Related risks include identification of pathogenic variants for PGT,negative impact of disease for PGT on ovarian reservation in female carriers,control of ovarian stimulation,and safety of ovarian simulation in hereditary cancer gene carriers.Risk management should be performed in different steps of the PGT processes.
NETL
NSTL
万方数据
